Filing Details
- Accession Number:
- 0001493152-22-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-03 16:15:50
- Reporting Period:
- 2021-12-29
- Accepted Time:
- 2022-01-03 16:15:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1641631 | Beyond Air Inc. | XAIR | Surgical & Medical Instruments & Apparatus (3841) | 473812456 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1702628 | A. Steven Lisi | C/O Beyond Air, Inc. 900 Stewart Avenue, Suite 301 Garden City NY 11530 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-29 | 21,376 | $9.53 | 1,150,111 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. (the "Company") sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units. The reporting person's sale of the Company's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 21,376 shares, with the reporting person's purchase of 25,000 shares of the Company's common stock at a weighted average price of $7.85 per share on August 13, 2021. The reporting person has paid to the Company, and the Company has received, $37,675, representing the full amount of the profit realized in connection with the short-swing transaction.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.70, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.